Daniel Edelstein
Daniel Edelstein
Research Scientist, Johns Hopkins School of Medicine
Verified email at jhu.edu
Cited by
Cited by
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
J Vidal, L Muinelo, A Dalmases, F Jones, D Edelstein, M Iglesias, M Orrillo, ...
Annals of Oncology 28 (6), 1325-1332, 2017
Rapid development of colorectal neoplasia in patients with Lynch syndrome
DL Edelstein, J Axilbund, M Baxter, LM Hylind, K Romans, CA Griffin, ...
Clinical gastroenterology and hepatology 9 (4), 340-343, 2011
Serrated polyposis: rapid and relentless development of colorectal neoplasia
DL Edelstein, JE Axilbund, LM Hylind, K Romans, CA Griffin, ...
Gut 62 (3), 404-408, 2013
Blood‐based detection of RAS mutations to guide anti‐EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing
W Schmiegel, RJ Scott, S Dooley, W Lewis, CJ Meldrum, P Pockney, ...
Molecular oncology 11 (2), 208-219, 2017
Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study
CJ Pendergrass, DL Edelstein, LM Hylind, BT Phillips, ...
Clinical Gastroenterology and Hepatology 6 (9), 1011-1015, 2008
Detection of tumor DNA at the margins of colorectal cancer liver metastasis
M Holdhoff, K Schmidt, F Diehl, N Aggrawal, P Angenendt, K Romans, ...
Clinical Cancer Research 17 (11), 3551-3557, 2011
Testosterone undecanoate in the treatment of male hypogonadism
D Edelstein, S Basaria
Expert opinion on pharmacotherapy 11 (12), 2095-2106, 2010
The latest options and future agents for treating male hypogonadism
D Edelstein, M Sivanandy, S Shahani, S Basaria
Expert opinion on pharmacotherapy 8 (17), 2991-3008, 2007
Risk of colorectal and other cancers in patients with serrated polyposis
DL Edelstein, M Cruz-Correa, M Soto-Salgado, JE Axilbund, LM Hylind, ...
Clinical Gastroenterology and Hepatology 13 (9), 1697-1699, 2015
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting
SP Rowe, B Luber, M Makell, P Brothers, JA Santmyer, ...
Molecular oncology 12 (10), 1661-1672, 2018
Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)
J Garcia, J Forestier, E Dusserre, AS Wozny, F Geiguer, P Merle, C Tissot, ...
Oncotarget 9 (30), 21122, 2018
Clinical characteristics of multiple colorectal adenoma patients without germline APC or MYH mutations
AH Tieu, D Edelstein, J Axilbund, KE Romans, LA Brosens, E Wiley, ...
Journal of clinical gastroenterology 50 (7), 584, 2016
A new phenotypic manifestation of familial adenomatous polyposis
DL Edelstein, FM Giardiello, A Basiri, LM Hylind, K Romans, JE Axilbund, ...
Familial cancer 10 (2), 309-313, 2011
Emerging drugs for hypogonadism
D Edelstein, A Dobs, S Basaria
Expert opinion on emerging drugs 11 (4), 685-707, 2006
Performance of standardized BEAMing platform for detecting RAS mutations in the blood of metastatic colorectal cancer (mCRC) patients.
FS Jones, D Edelstein, K Wichner, C Ross, K Stieler, V Boehm, E Lenfert, ...
Journal of Clinical Oncology 34 (15_suppl), 11538-11538, 2016
Profiling of circulating tumor DNA in plasma of non‐small cell lung cancer patients, monitoring of epidermal growth factor receptor p. T790M mutated allelic fraction using …
J Garcia, AS Wozny, F Geiguer, A Delherme, D Barthelemy, P Merle, ...
Cancer medicine 8 (8), 3685-3697, 2019
Concordance of RAS mutation status in metastatic CRC patients by comparison of results from circulating tumor DNA and tissue-based RAS testing
F Jones, D Edelstein, K Wichner, C Ross, F Holtrup
Detection of familial adenomatous polyposis with orthogonal polarized spectroscopy of the oral mucosa vasculature
A Basiri, DL Edelstein, J Graham, A Nabili, FM Giardiello, ...
Journal of biophotonics 4 (10), 707-714, 2011
Evaluating the biological activity and effects on human health of fish oil and its omega-3 fatty acids
AS Dobs, D Edelstein
Wild-Type Food in Health Promotion and Disease Prevention, 195-214, 2008
cfDNA for accurate determination of RAS and BRAF mutations using OncoBEAM liquid biopsy in metastatic colorectal cancer patients: Results of the real-world multicentric …
A Harle, C Gavoille, O Bouche, M Ben Abdelghani, JE Plaza, A Lambert, ...
Journal of Clinical Oncology 37 (15_suppl), 3542-3542, 2019
The system can't perform the operation now. Try again later.
Articles 1–20